📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
—
SENTIMENT
NEUTRAL
TOTAL VIEWS
0
CSTL Latest News & AI Sentiment Analysis
0 articles · Grade: — · Real-time AI-graded coverage
RECENT COVERAGE · 2 ARTICLES
Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth (NASDAQ:CSTL)
Castle Biosciences (CSTL) delivered a material guidance raise to $365M–$375M for 2026, signaling accelerating adoption of its core...
Castle Biosciences, Inc. (CSTL) Q2 2026 Earnings Call Transcript
Castle Biosciences (CSTL) reported Q2 2026 results via earnings call, representing a standard quarterly disclosure event. The company...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice